Orthokeratology Market By Product Type (Contact Lenses, Orthokeratology Lenses), By Application (Myopia Control, Astigmatism, Presbyopia), By Age Group (Pediatric, Adult), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Orthokeratology Market was valued at USD 502.6 million in 2024-e and will surpass USD 1,085.8 million by 2030; growing at a CAGR of 13.7% during 2025 - 2030.

The orthokeratology (Ortho-K) market is experiencing growth driven by the increasing prevalence of refractive errors such as myopia, astigmatism, and presbyopia. Ortho-K involves the use of specially designed contact lenses that are worn overnight to reshape the cornea, providing a non-surgical solution to correct vision. This technique is particularly popular in children for controlling the progression of myopia (nearsightedness), as well as in adults seeking to reduce dependence on glasses or contact lenses during the day. The growing awareness of the benefits of Ortho-K lenses, alongside the advancements in lens technology, is fueling the market's expansion.

The rising incidence of refractive vision problems globally, especially myopia, which has been identified as a growing concern in both developed and developing countries, is contributing to the increased adoption of Ortho-K lenses. Furthermore, the shift toward non-invasive and customizable treatments for vision correction is also supporting the growth of the market. Orthokeratology is being recognized for its potential in halting the progression of myopia in children, as well as offering a convenient and effective treatment for adults with refractive errors. With technological advancements in lens design and materials, the market is poised for significant growth in the coming years.

Orthokeratology Lenses Are Largest Product Type Segment Owing to Their Role in Myopia Control

Orthokeratology lenses, also known as Ortho-K lenses, are the largest product type segment in the market, driven by their critical role in myopia control, particularly in children. Ortho-K lenses are designed to reshape the cornea overnight, temporarily correcting refractive errors, and providing clear vision during the day without the need for glasses or traditional contact lenses. This non-invasive approach to myopia management has gained widespread acceptance among both parents and eye care professionals, especially for children who are at risk of progressive myopia.

Myopia is becoming more prevalent globally, especially in younger populations, and this trend has led to a growing demand for effective solutions to control its progression. Ortho-K lenses are a key intervention in slowing down myopia progression, reducing the need for higher prescriptions as children age. The popularity of Ortho-K lenses is further supported by their convenience, as patients can remove the lenses overnight and avoid the discomfort of wearing corrective lenses during the day. With their ability to provide long-term vision correction and myopia control, orthokeratology lenses are expected to remain the dominant product segment in the market.

Myopia Control Is Fastest-Growing Application Segment Owing to Rising Myopia Prevalence

Myopia control is the fastest-growing application segment in the orthokeratology market, driven by the rising prevalence of myopia, particularly in children and adolescents. Myopia is a refractive error in which distant objects appear blurred, and its increasing prevalence, especially among younger populations, has raised concerns about long-term eye health. As myopia progresses over time, it can lead to more severe vision issues, such as retinal detachment and glaucoma, making it crucial to manage its progression early. Orthokeratology has emerged as one of the most effective methods for controlling myopia progression, especially in pediatric patients.

The demand for myopia control is growing globally, as parents and healthcare professionals seek non-invasive alternatives to traditional glasses and contact lenses. Research has shown that orthokeratology can significantly slow down the elongation of the eye, which is the primary cause of worsening myopia. As more children are diagnosed with myopia at younger ages, the adoption of Ortho-K lenses for myopia control is expected to increase, making it the fastest-growing application segment. This growing concern about myopia and its potential impact on eye health is contributing to the increasing adoption of orthokeratology lenses as a preventive and corrective measure.

Pediatric Age Group Is Largest Segment Owing to Early Myopia Intervention

The pediatric age group is the largest segment in the orthokeratology market, primarily due to the increasing focus on early intervention for myopia in children. Myopia is often diagnosed in children as early as age 6, and if left untreated, it tends to progress rapidly during the early years of life. Early intervention is critical to prevent myopia from worsening and leading to more severe vision complications later in life. Orthokeratology lenses are one of the most effective non-surgical treatments available for controlling myopia progression in children.

Pediatric patients are increasingly being prescribed Ortho-K lenses as a preventive measure to manage the early onset of myopia. These lenses are especially popular because they offer a convenient, non-invasive solution that avoids the need for children to wear glasses or daily contact lenses. As the incidence of myopia in children continues to rise, driven by factors such as increased screen time and less time spent outdoors, the demand for orthokeratology lenses in pediatric populations is expected to grow. This focus on myopia control in children ensures that the pediatric age group remains the largest segment in the orthokeratology market.

North America Is Largest Region Owing to High Adoption Rates and Awareness of Myopia Control

North America is the largest region in the orthokeratology market, driven by high adoption rates of Ortho-K lenses and increasing awareness about the importance of myopia control. The United States, in particular, has witnessed a rise in the number of children diagnosed with myopia, leading to an increasing demand for effective myopia management solutions such as orthokeratology. North American consumers are highly receptive to new technologies and non-invasive treatments, and many parents seek orthodontic solutions for their children to prevent myopia from progressing.

Additionally, North America has a well-established healthcare system with a high level of access to eye care professionals, making it easier for patients to receive prescriptions for Ortho-K lenses. The growing recognition of the importance of myopia control in children, combined with a large number of optometrists and ophthalmologists offering orthokeratology services, has contributed to North America's dominance in the market. As the prevalence of myopia continues to rise in the region, North America will remain the largest market for orthokeratology lenses and myopia control treatments.

Competitive Landscape: Key Players and Market Trends

The orthokeratology market is competitive, with key players such as CooperVision, Essilor, Bausch & Lomb, and Menicon dominating the sector. These companies are leading the development of orthokeratology lenses and are continuously innovating to improve lens design, comfort, and effectiveness. CooperVision’s “MyDay” and Menicon’s “Menicon Z” are among the popular brands offering orthokeratology lenses for myopia control.

The market is also witnessing new entrants and smaller companies that are offering specialized Ortho-K lenses for different refractive errors such as astigmatism and presbyopia. As awareness of the benefits of orthokeratology grows, especially among pediatric patients, competition in the market is expected to intensify. Companies are focusing on technological advancements in lens materials and designs, with a particular emphasis on improving the comfort and wearability of Ortho-K lenses. Digital tools and 3D imaging are being integrated into the prescription process to customize lenses more precisely for individual patient needs. As the orthokeratology market continues to evolve, companies will need to differentiate themselves through innovation, quality, and customer service to maintain a competitive edge.

Recent Developments:

• In January 2023, CooperVision announced the launch of its latest generation of myopia control contact lenses with enhanced comfort.
• In October 2022, Bausch + Lomb received regulatory approval for its new line of orthokeratology lenses designed for patients with astigmatism.
• In February 2023, Euclid Systems introduced a new range of ortho-k lenses that offer a more rapid corneal reshaping process.
• In March 2023, Paragon Vision Sciences expanded its distribution of orthokeratology lenses across Asia.
• In July 2023, Menicon launched a breakthrough hybrid contact lens designed to improve comfort for long-term orthokeratology wearers.

List of Leading Companies:

• CooperVision
• Johnson & Johnson Vision Care
• Bausch + Lomb
• Euclid Systems
• OrthoKera
• Paragon Vision Sciences
• Visionary Optics
• EyeCare Professionals
• Toric Technologies
• MiSight (CooperVision)
• ART Optical
• Allergan
• Contamac
• Menicon
• No. 7 Contact Lenses

Report Scope: